Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac

Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Tang, Yuxiao, Plikaytis, Brian D., Preziosi, Marie-Pierre, Borrow, Ray
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639503/
https://ncbi.nlm.nih.gov/pubmed/26553685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ601
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky